HM Venture Partners
Overview
HM Venture Partners is a healthcare venture capital firm committed to accelerating the development of early and growth-stage healthcare companies by leveraging its team's expertise and extensive global ecosystem. The firm invests worldwide from its offices in San Francisco, California; Rochester, Minnesota; and Beijing, China. HM Venture Partners focuses on sectors such as biotech, medtech, healthcare IT, healthcare services, medical devices, biopharmaceuticals, diagnostics, healthcare AI, clinical research organizations, in vitro diagnostics, healthcare platforms, immunotherapy, oncology, cardiology, and respiratory diseases. The firm's investment strategy encompasses early and growth stages, with a geographical focus on the United States, China, and global markets. HM Venture Partners has a track record of successful investments, including OncoImmune Inc., a biopharmaceutical company acquired by Merck & Co., and OncoC4 Inc., a spin-off from OncoImmune. The firm's portfolio also includes Airiver Medical Inc., which develops drug-coated balloons for treating airway stenosis and asthma. HM Venture Partners is dedicated to partnering with category-defining healthcare businesses, contributing to the innovation and development of the healthcare landscape. The firm's team comprises professionals with extensive experience in investment, entrepreneurship, operations, management, life sciences research, and clinical practice, providing valuable support to its portfolio companies.
Investment Focus
- Innovative healthcare solutions
- Strong management teams
- Scalable business models
- Global market potential
- Regulatory compliance
Portfolio Companies
Reach HM Venture Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about HM Venture Partners
What sectors does HM Venture Partners invest in?
HM Venture Partners invests in Healthcare Services, Medical Devices, Diagnostics, Biotech, Medtech and Immunotherapy, and is based in California, United States. HM Venture Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does HM Venture Partners invest at?
HM Venture Partners backs companies at Early Stage and Growth.
Which regions does HM Venture Partners invest in?
HM Venture Partners invests across United States, China and Global.
Who are the partners at HM Venture Partners?
Team members listed for HM Venture Partners include Yang Liu (Founder) and Yi Guo (Chief Scientific Officer).
What companies has HM Venture Partners invested in?
HM Venture Partners's portfolio includes OncoImmune Inc., OncoC4 Inc. and Airiver Medical Inc..
How do I contact HM Venture Partners?
HM Venture Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database